Swisscom Health to take over Galenica practice information system
Approx. 2,000 doctors currently use Swisscom Health’s curaPrax. The Swisscom subsidiary is now to double its regular cus…
Approx. 2,000 doctors currently use Swisscom Health’s curaPrax. The Swisscom subsidiary is now to double its regular cus…
Galenica's U.S. partner, Luitpold Pharmaceuticals, Inc., has received confirmation from the US Food and Drug Administrat…
The Galenica Group recorded profit growth for the 17th consecutive year in 2012: consolidated net profit rose 13.6% to C…
Despite a tense economic situation and global pressure on healthcare costs, the Galenica Group has posted a good result…
Galenica's U.S. partner, Luitpold Pharmaceuticals, Inc., has received a Complete Response Letter from the US Food and Dr…
The Galenica Group posted new record results for 2011, achieving its 16th consecutive year of double-digit profit growth…
Despite the currency crisis and a difficult economic environment, the Galenica Group contin-ued to grow in 2011 and gene…
Galenica has acquired all of the outstanding shares of Vifor Uriach Pharma SL, a joint venture with its Spanish partner…
The common company of Galenica and Fresenius Medical Care - Vifor Fresenius Medical Care Renal Pharma Ltd. (Vifor FMC Re…
Galenica has been strongly affected by the significant drop of both dollar and euro. While the Group generates around tw…